作者: Marissa Howard-McNatt , Julia Lawrence , Susan A. Melin , Edward A. Levine , Perry Shen
DOI: 10.1016/J.AMJSURG.2013.01.009
关键词:
摘要: BACKGROUND: Black women can have worse outcomes than white with breast cancer. We examined survival in black and who received neoadjuvant chemotherapy. METHODS: identified 98 stage II or III cancer underwent Women inflammatory cancer, T4 disease, metastases were excluded. Data analyzed using the Fisher exact test Kaplan-Meier method. RESULTS: From cohort, 69 included. The median follow-up was 6.2 years. estrogen receptor status similar. White tended to overexpress human epidermal growth factor 2 (HER2) (P 5.091). pretreatment T T3. All similar 5-year progression-free better for compared (78% vs 58%, P 5 .05). overall .095). CONCLUSIONS: characteristics of receiving chemotherapy had a disease-free survival. same.